Skip to the page

Data / Form D filings / CHARM Therapeutics Inc.

CHARM Therapeutics Inc.: Form D filings

CHARM Therapeutics Inc., a company in London, United Kingdom, filed 4 Form D notices with the SEC between 2021 and 2025. The latest, on September 3, 2025, reports $17.3 million sold of a $80.1 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7 PANCRAS SQUARE, London, United Kingdom, N1C 4
Phone
447582703655
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1889676

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 3, 2025New notice$80,095,754$17,290,119$62,805,63520Aug 19, 2025sec.gov
Apr 14, 2023New notice$20,045,588$20,045,5882Apr 6, 2023sec.gov
Jun 24, 2022New notice$36,999,990$36,999,99018Apr 18, 2022sec.gov
Oct 22, 2021New notice$13,500,000$12,645,000$855,0008Oct 14, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Gary GlickExecutive Officer, Director, Promoter
Mahesh KudariDirector
Briggs MorrisonDirector
Nihal SinhaDirector
Kim BlackwellDirector
Matthew McAvineyDirector
Rishi GuptaDirector

Every Form D from the week of Sep 1, 2025 · All recent Other filings

Read from SEC EDGAR. Amount sold is what CHARM Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.